Evaluation of Double Self-Immolative Linker-Based Antibody-Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential.
Zhang Y, Wang L, Cao X, Song R, Yin S, Cheng Z, Li W, Shen K, Zhao T, Xu J, Liu S, Xie Q, Wu Y, Gao B, Guo Q, Wu J, Qiu X, Wang B, Zhang W, Yang T, Lu W, Zhu S.
Zhang Y, et al. Among authors: song r.
J Med Chem. 2024 Oct 23. doi: 10.1021/acs.jmedchem.4c02243. Online ahead of print.
J Med Chem. 2024.
PMID: 39444220